The trial was investigating the use of vagus nerve stimulation (VNS) for inflammatory bowel disease (IBD), an autoimmune ...

The pharma will pay $200 million to buy Nimble and a preclinical oral drug that blocks a protein known as IL-23 — the target ...

This is thought to keep the inflammation from IBD in check. However, this also means that the body is less able to fight off infections, such as those that are caused by bacteria or viruses, including ...

“In acute flares, these drugs may complicate the situation by masking symptoms without addressing underlying inflammation.” ...

Hong Kong-based Insilico Medicine said its generative artificial intelligence (AI) platforms helped it design a molecule that ...

Background Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), poses a substantial disease burden worldwide. Recent studies have indicated that anti-diabetic ...

ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the ...

Inflammatory bowel disease (IBD), consisting primarily of ulcerative colitis and Crohn's disease, is a group of debilitating ...

ISM5411 is designed to directly regulate the intestinal immune microenvironment so that the drug simultaneously reduces the gut inflammation seen in IBD while also promoting the repair of the ...

"This collaboration demonstrates a commitment to ensuring that all passengers, no matter their health condition, are treated ...

Veterans with inflammatory bowel disease (IBD) prioritize shared decision-making ... Biosimilar switching programs offer the ...